Li Ka Shing Building
291 Campus Drive, Palo Alto, CA 94305
USA
Presenters: Paul Kwo, MD and Jeffrey Glenn, MD,PhD
Kwo: Professor of Medicine, Gastroenterology and Hepatology
Glenn: Associate Professor of Medicine, Gastroenterology and Hepatology, & Microbiology and Immunology
Stanford University
Paul Kwo, MD, is currently Professor of Medicine and Director of Hepatology at the Stanford University where he joined the faculty in November 2016. Prior to joining the faculty at Stanford, he was at Indiana University for 21 years where he served as the Medical Director of Liver Transplantation. He has distinguished himself in the field of chronic Hepatitis C and has a large practice devoted to current and novel therapies for the treatment of Hepatitis C. He recently authored the pACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.
Jeffrey Glenn, MD, PhD,’s primary interest is in molecular virology, with a strong emphasis on translating this knowledge into novel antiviral therapies. Current projects aim to better understand the role of prenylation in the life cycles of hepatitis delta virus (HDV) and other viruses-both as a mechanism of intracellular trafficking and trigger of virus assembly, and as a target for a promising antiviral treatment. The function and cell biology of the hepatitis C virus (HCV) non-structural proteins are also being studied. Here the focus is on identifying key determinants of pathogenesis and designing novel antiviral strategies. Other interests include exploitation of hepatic stem cells, development of a small animal model for HCV, and engineered human liver tissues.